Psychosis and schizophrenia in adults: updated NICE guidance for 2014

shutterstock_91081991

While the organisation’s name may change frequently, currently National Institute for Health and Care Excellence (NICE), its role remains constant – to provide clear published guidance on the role of treatment options within the NHS. The publication of new NICE guidance represents a significant event as clinical recommendations shape the nature of provided care nationally [read the full story...]

New NICE guidance recommends that all NHS hospitals and clinics become completely smoke-free

shutterstock_123153616

Over 40% of all cigarettes smoked in England are smoked by people with severe mental illnesses. This group are more likely to become physically ill than the rest of the population, but they are less likely to be given help to quit. Smoking is especially common among people with mental health problems: whilst 1 in [read the full story...]

New Australian guidelines for the treatment of ASD and PTSD in children

shutterstock_129436619

Do not use psychological debriefing when a child has been exposed to a traumatic event such as assault or a major car crash. And if you treat a child who has developed Posttraumatic Stress Disorder (PTSD) due to trauma, do not use pharmacotherapy either (that is, not as a first line treatment). Rather, apply the [read the full story...]

Primary care interventions for alcohol misuse: US Preventative Services Task Force recommendations

shutterstock_141815629

Alcohol misuse is recognised as one of the major health care issues in the US. Specifically, alcohol misuse is ranked third in causes of preventable deaths (after tobacco and obesity) affecting 30% of the population. Alcohol dependence has 4% prevalence in the US, but hazardous drinking patterns are believed to be evident in 21% of [read the full story...]

NICE publish new Quality Standard and Evidence Update on ADHD

Young girl riding bike

Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioural disorder in the UK, with sufferers experiencing inattentiveness, hyperactivity, and impulsivity. It is estimated to affect 3-9% of school aged children and young people in the UK (those aged 3 to 18), and 2% of adults worldwide (DSM-IV criteria). Typically ADHD will continue from childhood [read the full story...]

Lack of evidence to support QOF incentives for assessing depression severity using tools in primary care

Form filling

Introduction The quality and outcomes framework was set up in 2004 to incentivise aspects of clinical practice within general practice in the UK. Two standards which are incentivised in depression are DEP4 (the percentage of patients who have had assessment of severity at diagnosis using a tool validated for use in primary care (PHQ-9, BDI-II, [read the full story...]

Share this post: Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+ Share via email

New NICE TA: Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder

Pills

NICE has just published a new technology appraisal recommending aripiprazole as a treatment for bipolar disorder in young people. Technology Appraisals are systematic evaluations of the effectiveness of health technologies.  They do not have the broad scope of guidelines, which focus on topics rather than technologies, but they do give guidance for clinical practice on the [read the full story...]

The latest evidence from NICE on depression in children and young people

Young boy on roundabout

The NICE guideline for depression in children and young people was published way back in September 2005.  Any elf worth his salt will tell you that a whole heap of evidence has been published since then, so it’s good to see an evidence update appear this week from NICE, which brings together research published from 17th [read the full story...]

NICE publish first clinical guideline on social anxiety disorder

Social humiliation

I wonder if the timing of this publication was planned to be so close to the release of DSM-5, but this debut guidance on social phobia (now known as social anxiety disorder) is certainly going to ruffle some feathers. It fuels the discussion about the medicalisation of human personality traits and some will see it [read the full story...]

New guideline says lithium still appears to have the most robust evidence base as a long-term treatment for bipolar disorder

Bipolar

Bipolar disorder features as one of the top ten disabling disorders for working age adults. There are numerous risks including suicide, increased mortality and reduced social functioning associated with the disorder. Key to enabling recovery is preventing acute episodes from occurring, with each episode increasing the risk of future ones. Therefore ensuring long-term maintenance treatment [read the full story...]